This transport protein is known as the sodium dependent organic cation transporter or OCTN2
Their perspectives illustrate how GLP-1 medications are raising new questions about cost, utilization, and long-term risk for insurers and policymakers
Biomolecules 15(1):46 Lin L et al (2022) Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial
Educational Resources: LifeMD offers extensive educational materials to help you understand your treatment and promote overall health
Our BEAM, PRYZM, and CTLYST platforms provide critical insights for identifying development programs, acquisition targets, and investment opportunities
Diabetes Care 42 , S46S60 (2019)